CLEAR CELL RENAL CELL CARCINOMA (CCRCC)
Clinical trials for CLEAR CELL RENAL CELL CARCINOMA (CCRCC) explained in plain language.
Never miss a new study
Get alerted when new CLEAR CELL RENAL CELL CARCINOMA (CCRCC) trials appear
Sign up with your email to follow new studies for CLEAR CELL RENAL CELL CARCINOMA (CCRCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Personalized vaccine trial offers new hope for advanced kidney cancer patients
Disease control Not yet recruitingThis is a very early study to check the safety and initial effects of a new personalized vaccine called KSD-201 for people with advanced kidney cancer that has stopped responding to standard treatments. Doctors will make the vaccine from the patient's own immune cells and give it…
Matched conditions: CLEAR CELL RENAL CELL CARCINOMA (CCRCC)
Phase: EARLY_PHASE1 • Sponsor: Kousai Bio Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New scan aims to spot hidden kidney cancer
Diagnosis Not yet recruitingThis study is testing a new type of PET scan to see if it can better detect leftover or returning kidney cancer after a patient's initial treatment. Researchers will give participants a special imaging drug and then perform scans to see if the cancer lights up. The goal is to imp…
Matched conditions: CLEAR CELL RENAL CELL CARCINOMA (CCRCC)
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Diagnosis
Last updated Mar 23, 2026 15:19 UTC